Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03522649 |
|---|---|
| Brief Title: | A Phase III Clinical Study of Napabucasin (GB201) Plus FOLFIRI in Adult Patients With Metastatic Colorectal Cancer |
| First Submitted : | May 1, 2018 |
| First Submitted that Met QC Criteria : | May 1, 2018 |
| First Posted : | May 11, 2018 |
| Last Update Submitted that Met QC Criteria : | June 17, 2019 |
| Last Update Posted : | June 18, 2019 |